Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;289(6):887-894.
doi: 10.1111/joim.13232. Epub 2021 Jan 29.

Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study

Arvind Julius Trindade  1   2 , Stephanie Izard  1 , Kevin Coppa  3 , Jamie S Hirsch  1   3   4 , Calvin Lee  5 , Sanjaya K Satapathy  6 ; Northwell COVID-19 Research Consortium
Affiliations
Free article

Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study

Arvind Julius Trindade et al. J Intern Med. 2021 Jun.
Free article

Abstract

Background and aims: Gastrointestinal (GI) bleeding has been observed amongst patients hospitalized with COVID-19. Recently, anticoagulation has shown to decrease mortality, but it is unclear whether this contributes to increased GI bleeding. The aims of this study are: (i) to examine whether there are risk factors for GI bleeding in COVID-19 patients and (ii) to study whether there is a mortality difference between hospitalized patients with COVID-19 with and without GI bleeding.

Methods: This is a propensity score matched case-control study from a large health system in the New York metropolitan area between March 1st and April 27th. COVID-19 patients with GI bleeding were matched 1:1 to COVID-19 patients without bleeding using a propensity score that took into account comorbidities, demographics, GI bleeding risk factors and length of stay.

Results: Of 11, 158 hospitalized with COVID-19, 314 patients were identified with GI bleeding. The point prevalence of GI bleeding was 3%. There were no identifiable risk factors for GI bleeding. Use of anticoagulation medication or antiplatelet agents was not associated with increased risk of GI bleeding in COVID-19 patients. For patients who developed a GI bleed during the hospitalization, there was an increased mortality risk in the GI bleeding group (OR 1.58, P = 0.02).

Conclusion: Use of anticoagulation or antiplatelet agents was not risk factors for GI bleeding in a large cohort of hospitalized COVID-19 patients. Those with GI bleeding during the hospitalization had increased mortality.

Keywords: SARS-CoV-2; anticoagulation; endoscopy; hematochezia; melena.

PubMed Disclaimer

References

    1. Nuzzo J, Moss B, Kahn J et al. Johns Hopkins University Coronavirus Resource Center. 2020. https://coronavirus.jhu.edu/. Accessed 27 December, 2020.
    1. Inamdar S, Benias PC, Liu Y, Sejpal DV, Satapathy SK, Trindade AJ. Prevalence, risk factors, and outcomes of hospitalized patients with COVID-19 presenting as acute pancreatitis. Gastroenterology 2020; 159: 2226-8.
    1. Nobel YR, Phipps M, Zucker J et al. Gastrointestinal symptoms and COVID-19: case-control study from the United States. Gastroenterology 2020; 159: 373-5.
    1. Gadiparthi C, Perisetti A, Sayana H, Tharian B, Inamdar S, Korman A. Gastrointestinal bleeding in patients with severe SARS-CoV-2. Am J Gastroenterol 2020; 115: 1283-5.
    1. Cavaliere K, Levine C, Wander P, Sejpal DV, Trindade AJ. Management of upper GI bleeding in patients with COVID-19 pneumonia. Gastrointest Endosc 2020; 92: 454-5.

LinkOut - more resources